Red light therapy
Emerging evidenceWhy it might help
Red and blue LED photobiomodulation is thought to modulate cutaneous inflammation and vascular reactivity, which may reduce visible redness and the inflammatory bumps seen in rosacea.
What the research shows
Small, mostly uncontrolled studies and case reports suggest LED light therapy may reduce facial erythema and inflammatory lesions in some people with rosacea, but the evidence is early and larger controlled trials are needed. It is best viewed as a possible adjunct, not a replacement for dermatologic care.
Sources & what they found (2)
Graded claim from the Praxium evidence graph
Across small case series and one 9-patient single-arm trial (Wade 2021), LED phototherapy - blue (~447-480 nm) plus red (650 nm) light and biophotonic fluorescent light energy (FLE/Kleresca) - reduced papulopustular inflammation, flushing and erythema in rosacea with good tolerability. The evidence is early: mostly uncontrolled case reports/series without blinding, so the true effect size is uncertain. A reasonable adjunct to standard anti-inflammatory rosacea therapy, not a replacement.
How strong the finding is
9 studies in base (1 review, 5 human, 1 animal, 1 in vitro, 1 other); grounding = 4 human (Braun 2017, Sorbellini 2020, Wade 2021 n=9 single-arm, Sannino 2018), all directionally toward reduced erythema/inflammation.
What complicates this
Predominantly case reports/series, small n, no controls or blinding, heterogeneous devices and wavelengths (blue vs red vs FLE), short follow-up; placebo and regression-to-mean not excluded.
